Patent US837379A successfully refreshed from Google Patents.
Patent US2746209A successfully refreshed from Google Patents.
Patent US4950599A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4950599A Expired / Lapsed US ⏱️ 0.0 years remaining

Method for exchanging homologous DNA sequences in a cell using polyoma encapsulated DNA fragments

Assignee: Individual
•
Filing: 1987-01-29
•
Granted: 1990-08-21
•
Expires: 2007-01-29
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method for altering a cell by exchanging a preselected cellular DNA sequence with an exogenous DNA sequence different from the cellular DNA sequence employs an exogenous DNA sequence encapsidated in a polyoma or polyoma-like capsid. The polyoma capsid is then contacted to the cell so that the exogenous DNA sequence is introduced within the cell and exchanges with the preselected cellular DNA sequence by homologous recombination. A preferred article of manufacture comprises a polyoma capsid and a plurality of DNA sequences encapsulated within the polyoma capsid. The DNA sequences each comprise not more than an incomplete portion of a single preselected gene. The exogenous DNA sequence may optionally be complexed to a DNA binding protein, such as a recA protein, prior to encapsulating the exogenous DNA sequence within a viral capsid, so that the uptake of the DNA sequence into the capsid is enhanced.

Inventors

  • 👤 Wolf Bertling

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-04 12:17
CPC Classifications
C; C12; C12N; C12N15/00; C12N15/09; C12N15/63; C12N15/79; C12N15/85; C12N15/86; A; A61; A61K; A61K47/00; A61K47/50; A61K47/69; A61K47/6901; C12N15/87; C12N15/90; C12N15/902; C12N15/907; C12N2710/00; C12N2710/00011; C12N2710/22011; C12N2710/22022; C12N2710/22023; C12N2710/22041; C12N2710/22042; C12N2795/00; C12N2795/00011; C12N2795/14011; C12N2795/14111; C12N2795/14122; Y; Y10; Y10S; Y10S435/00; Y10S435/8215; Y10S435/948

Claims Analysis

Total Claims: 21
Claim 1
Independent Claim 113 words
A method of altering, by homologous recombination, a preselected chromosomal DNA sequence encoding a protein in a polyoma-permissive cell, said method comprising the steps of: (a) providing a polyoma capsid having at least one single-stranded exogenous DNA sequence encapsulated therein, said exogenous DNA sequence consisting essentially of a DNA sequence sufficiently homologous to said preselected chromosomal DNA sequence and of a length suitable to anneal to the complement of said homologous DNA sequence, and (b) contacting said polyoma capsid to said polyoma-permissive cell so that said exogenous DNA sequence is introduced within said cell, anneals to the complement of said homologous DNA sequence, and exchanges with said chromosomal DNA sequence by homologous recombination.
Claim 2
Independent Claim 113 words
A method of altering, by homologous recombination, a preselected chromosomal DNA sequence encoding a protein in a polyoma-permissive cell, said method comprising the steps of: (a) providing a polyoma capsid having at least one single-stranded exogenous DNA sequence encapsulated therein, said exogenous DNA sequence consisting essentially of a DNA sequence sufficiently homologous to said preselected chromosomal DNA sequence and of a length suitable to anneal to the complement of said homologous DNA sequence, and (b) contacting said polyoma capsid to said polyoma-permissive cell so that said exogenous DNA sequence is introduced within said cell, anneals to the complement of said homologous DNA sequence, and exchanges with said chromosomal DNA sequence by homologous recombination.
Claim 3
Dependent Claim 35 words
A method according to claim 1, wherein said chromosomal DNA sequence comprises an incomplete portion of an endogenous structural gene in said cell, and wherein said exogenous DNA sequence is a fragment of said gene.
Claim 4
Dependent Claim 14 words
A method according to claim 1, wherein said polyoma-permissive cell is a mammalian cell.
Claim 5
Dependent Claim 21 words
A method according to claim 1, wherein said viral capsid has more than one of said exogenous DNA sequence encapsulated therein.
Claim 6
Dependent Claim 21 words
A method according to claim 1, wherein said exogenous DNA sequence is from about 50 to about 5,000 nucleotides in length.
Claim 7
Dependent Claim 13 words
A method according to claim 1, wherein said exogenous DNA sequence is single-stranded.
Claim 8
Dependent Claim 16 words
A method according to claim 6, wherein said exogenous DNA sequence has recA protein complexed thereto.
Claim 9
Dependent Claim 20 words
A method according to claim 1, wherein said exogenous DNA sequence is double-stranded, said double-stranded DNA sequence having protruding ends.
Claim 10
Dependent Claim 26 words
A method according to claim 8, wherein said protruding ends are modified to prevent the polymerization of said double-stranded DNA segment with a like DNA segment.
Claim 11
Dependent Claim 64 words
An article of manufacture useful for altering by homologous recombination a preselected chromosomal DNA sequence encoding a protein in a polyoma-permissive cell, said article comprising a polyoma viral capsid and at least one exogenous DNA sequence encapsulated within said polyoma viral capsid, said exogenous DNA sequence being sufficiently homologous to a strand of said preselected chromosomal DNA sequence to anneal to the complement thereof.
Claim 12
Dependent Claim 64 words
An article of manufacture useful for altering by homologous recombination a preselected chromosomal DNA sequence encoding a protein in a polyoma-permissive cell, said article comprising a polyoma viral capsid and at least one exogenous DNA sequence encapsulated within said polyoma viral capsid, said exogenous DNA sequence being sufficiently homologous to a strand of said preselected chromosomal DNA sequence to anneal to the complement thereof.
Claim 13
Dependent Claim 24 words
An article of manufacture as claimed in claim 10, wherein said exogenous DNA sequence consists of a fragment of said preselected chromosomal DNA sequence.
Claim 14
Dependent Claim 25 words
An article of manufacture as claimed in claim 10, wherein more than one of said exogenous DNA sequence is encapsulated within said polyoma viral capsid.
Claim 15
Dependent Claim 23 words
An article of manufacture as claimed in claim 10, wherein said DNA sequence is from about 50 to about 5,000 nucleotides in length.
Claim 16
Dependent Claim 18 words
An article of manufacture as claimed in claim 10, wherein said DNA sequence comprises a single-stranded DNA sequence.
Claim 17
Dependent Claim 17 words
An article of manufacture as claimed in claim 10, wherein said DNA sequence has RecA complexed thereto.
Claim 18
Dependent Claim 22 words
An article of manufacture as claimed in claim 10, wherein said DNA sequence is double-stranded, said double-stranded DNA sequence having protruding ends.
Claim 19
Dependent Claim 29 words
An article of manufacture as claimed in claim 16, wherein said protruding ends are modified to prevent the polymerization of said double-stranded DNA segment with a like DNA segment.
Claim 20
Dependent Claim 66 words
An article of manufacture useful for altering by homologous recombination a preselected chromosomal DNA sequence encoding a protein in a polyoma-permissive cell, said article comprising a polyoma capsid and at least one DNA sequence encapsulated within said polyoma capsid, said DNA sequence comprising not more than an incomplete portion of said chromosomal DNA sequence and having a length of from about 100 to about 300 nucleotides.
Claim 21
Dependent Claim 66 words
An article of manufacture useful for altering by homologous recombination a preselected chromosomal DNA sequence encoding a protein in a polyoma-permissive cell, said article comprising a polyoma capsid and at least one DNA sequence encapsulated within said polyoma capsid, said DNA sequence comprising not more than an incomplete portion of said chromosomal DNA sequence and having a length of from about 100 to about 300 nucleotides.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1993-08-20 1994-02-19 1994-08-21 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1997-08-20 1998-02-19 1998-08-21 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2001-08-20 2002-02-19 2002-08-21 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag